Health News

Press Release Oncology Venture’s Novel PARP Inhibitor Stenoparib …

-Company to advance Stenoparib into human clinical trials as a potential therapy for COVID-19 -Company provides updates on prioritized Stenoparib program in Ovarian cancer … Read More
All copyrights for this article are reserved to Medical Supplies & PPE

Leave a comment

Your email address will not be published. Required fields are marked *

Tap to call MyPPE
error: Alert: Content is protected !!